AGENTS LIANTS BISPÉCIFIQUEMENT SCLÉROSTINE ET DKK-1
- 专利权人:
- Amgen Inc.
- 发明人:
- 申请号:
- EP12708472.1
- 公开号:
- EP2681242B1
- 申请日:
- 2012.02.29
- 申请国别(地区):
- EP
- 年份:
- 2018
- 代理人:
- 摘要:
- The invention relates to bispecific anti-sclerostin/anti-DKK1 binding agents and combinations of anti-sclerostin and anti-DKK1 binding agents, and related methods of treatment.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- PPAR-SPARING THIAZOLIDINEDIONES AND COMBINATIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
- Ppar-sparing thiazolidiones and combinations for the treatment of neurodegenerative diseases
- METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
- QUINAZOLINE INHIBITORS OF BACE 1 AND METHODS OF USING
- ПРОИЗВОДНЫЕ 6,7-ДИГИДРОПИРАЗОЛО[1,5-a]ПИРАЗИН-4-ИЛАМИНА, ПРИГОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ БЕТА-СЕКРЕТАЗЫ (BACE)